Cytotrait Ltd.

Cytotrait Ltd. , based in the UK, specializes in developing advanced agricultural traits using innovative technology to enhance crop yields and resilience, addressing global food security challenges. Cytotrait Ltd. is a UK-based firm established in 2023 in Manchester, focusing on agricultural biotechnology to improve crop traits.

The company has completed one significant deal to date. It raised GBP 3 million in SEED funding on March 9, 2026, led by Northern Gritstone with contributions from Future Planet Capital and Parkwalk Advisors, bringing the total amount raised to GBP 3 million. The founder's history is not specified, but the company operates independently without known subsidiaries. Cytotrait specializes in developing advanced agricultural traits through its proprietary technology known as the Mutant Organelle Selection System (MOSS).

This innovative method enables the targeted introduction of genes into chloroplasts and mitochondria, facilitating rapid homoplasmy for enhanced crop yields and resilience against environmental stresses. Their primary services aim to improve food production traits for agricultural biotechnology firms, seed companies, and farmers, focusing on markets in North America, Europe, and Asia. Cytotrait generates revenue through partnerships with agricultural businesses, leveraging its MOSS technology to develop customized genetic traits for their clients. Transactions typically occur in a B2B framework, involving project-based contracts or licensing agreements, allowing flexibility in pricing to meet diverse agricultural needs.

In March 2026, Cytotrait Ltd. raised GBP 3 million in SEED funding to expand research programs utilizing its MOSS platform for developing crop traits in wheat, maize, potato, and canola. The company plans to enhance its offerings by targeting new markets in North America, Europe, and Asia, with a focus on addressing food security challenges through innovative agricultural solutions.